MHD patients with COVID-19 had elevated infection-related biomarkers, including CRP, ESR, procalcitonin, IL-6, IL-2R and TNF-α, which likely reflected an exacerbated inflammatory response. This evidence concerns the gene IL6 and COVID-19.